Medicare Enrolled
Dr. Warren Wexelman, M.D.
Cardiovascular Disease · Brooklyn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wexelman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wexelman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wexelman
Dr. Warren Wexelman is a cardiovascular disease specialist in Brooklyn, NY, with 21 years of NPI registration. Based on federal Medicare data, Dr. Wexelman performed 2,927 Medicare services across 1,755 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wexelman received a total of $460,552 from 35 pharmaceutical and/or device companies across 988 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wexelman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 32% volume in NY
$460,552 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,927
Medicare services
Top 32% in NY for cardiovascular disease
1,755
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~139 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
621 | $8 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
587 | $101 | $250 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
532 | $12 | $50 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
318 | $70 | $200 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
85 | $3 | $10 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
64 | $45 | $80 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
64 | $36 | $70 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
63 | $48 | $95 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
60 | $72 | $150 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
59 | $36 | $40 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
58 | $76 | $85 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
56 | $181 | $500 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
47 | $149 | $300 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
36 | $174 | $400 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
33 | $140 | $325 |
| New patient office visit, complex (60-74 min) | 33 | $175 | $358 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
32 | $224 | $428 |
| Complete ultrasound of abdomen and pelvis blood flow This procedure uses sound waves to create images of blood flow in the arteries and veins of the abdomen and pelvis. It evaluates the rate and direction of blood movement within these vessels. |
32 | $248 | $525 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
31 | $172 | $425 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
25 | $10 | $35 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
24 | $65 | $275 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording, analyzing, and interpreting a continuous external electrocardiogram (EKG) over a period of more than 48 hours up to 7 days. |
22 | $247 | $800 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $157 | $325 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
14 | $46 | $110 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
11 | $19 | $45 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.0% high complexity
5.3% medium
91.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$460,552
Total received (2018-2024)
Avg $65,793/year across 7 years
Top 1% in NY for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
988
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$429,550 (93.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$20,494 (4.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,174 (2.2%)
Other
Charitable contributions, space rental, and other categories
$334 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$18,424
2023
$101,221
2022
$108,964
2021
$18,501
2020
$50,350
2019
$57,717
2018
$105,375
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$11,631
Novartis Pharmaceuticals Corporation
$4,430
AstraZeneca Pharmaceuticals LP
$845
Corcept Therapeutics
$319
Lilly USA, LLC
$251
Intra-Sana Laboratories
$238
GlaxoSmithKline, LLC.
$196
Novo Nordisk Inc
$103
HEARTFLOW, INC.
$95
Janssen Pharmaceuticals, Inc
$84
Boehringer Ingelheim Pharmaceuticals, Inc.
$75
Amgen Inc.
$57
E.R. Squibb & Sons, L.L.C.
$29
Edwards Lifesciences Corporation
$28
CeQur Corporation
$25
Xeris Pharmaceuticals, Inc.
$17
Top 3 companies account for 91.8% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme LLC
$193,293
AstraZeneca Pharmaceuticals LP
$97,051
Amgen Inc.
$57,371
Gilead Sciences, Inc.
$47,702
Novartis Pharmaceuticals Corporation
$31,736
Janssen Pharmaceuticals, Inc
$15,579
Novo Nordisk Inc
$5,384
Merck Sharp & Dohme Corporation
$4,424
Medtronic Vascular, Inc.
$1,994
BOSTON SCIENTIFIC CORPORATION
$1,795
Lilly USA, LLC
$491
PFIZER INC.
$483
Boehringer Ingelheim Pharmaceuticals, Inc.
$399
Abbott Laboratories
$382
Welch Allyn
$334
Corcept Therapeutics
$319
Regeneron Healthcare Solutions, Inc.
$291
GlaxoSmithKline, LLC.
$270
Intra-Sana Laboratories
$257
Edwards Lifesciences Corporation
$200
Boston Scientific Corporation
$145
SANOFI-AVENTIS U.S. LLC
$132
Amarin Pharma Inc.
$120
HEARTFLOW, INC.
$95
E.R. Squibb & Sons, L.L.C.
$59
Allergan Inc.
$49
Horizon Therapeutics plc
$34
CeQur Corporation
$25
Exact Sciences Corporation
$23
Aegerion Pharmaceuticals, Inc.
$22
Bayer HealthCare Pharmaceuticals Inc.
$21
Kowa Pharmaceuticals America, Inc.
$21
Takeda Pharmaceuticals U.S.A., Inc.
$18
Xeris Pharmaceuticals, Inc.
$17
AbbVie Inc.
$16
Top 3 companies account for 75.5% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · AREXVY · Adempas · Aimovig · BASAGLAR · BRILINTA · BYDUREON · BYSTOLIC · CAMZYOS · CHANTIX · CeQur Simplicity · Cologuard Collection Kit · Confirm Rx · CoreValve Evolut · Corlanor · DUPIXENT · ELIQUIS · ENTRESTO · EVENITY · EVKEEZA · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FASENRA · FFRct · GVOKE HYPOPEN · HeartMate 3 Left Ventricular Dev · JANUVIA · JARDIANCE · JUXTAPID · Korlym · LEQVIO · LINZESS · Livalo · MOUNJARO · MULTAQ · Merlin Connectivity and Remote · Mitra Clip system · MitraClip System · NUCALA · None · Otezla · Ozempic · PAXLOVID · PENNSAID · PRADAXA · PRALUENT · Prolia · RAYOS · RELTONE 200 MG · RYBELSUS · Ranexa · Repatha · Rybelsus · SAPIEN 3 Ultra RESILIA · SHINGRIX · SOLIQUA 100/33 · TEZSPIRE · TRELEGY ELLIPTA · TRULICITY · Trintellix · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for cardiovascular disease in NY.
Geographic Context
Cardiologists within 10 mi
1,795
Per 100K population
67.8
County median income
$78,548
Nearest hospital
NEW YORK COMMUNITY HOSPITAL OF BROOKLYN, INC.
1.8 mi
1.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wexelman is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of NY peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wexelman experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Wexelman performed 621 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wexelman receive payments from pharmaceutical companies?
Yes. Dr. Wexelman received a total of $460,552 from 35 companies across 988 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wexelman's costs compare to other cardiologists in Brooklyn?
Dr. Wexelman's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wexelman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Brooklyn
Browse cardiologists in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NY
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NY
Which NY cardiologists receive the most from drug and device companies.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology